日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Serum IL-13 and IL-31 Levels are not Attenuated upon Dupilumab Treatment: Lessons from a Prospective Cohort

杜普利尤单抗治疗后血清IL-13和IL-31水平并未降低：一项前瞻性队列研究的启示

期刊:Acta Dermato-Venereologica
影响因子:3.7
doi:10.2340/actadv.v106.adv-2025-0147
Suleiman, Ghazal; Boyango, Ilanit; Dawood, Marwan; Mirmovitch-Morvay, Orna; Avitan-Hersh, Emily
IL-31
IL-13
IL-3
发表日期：2026
文献求助 收藏

The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort study

免疫检查点诱导的大疱性类天疱疮的免疫表型：一项队列研究

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04172-3
Saffuri, Nada; Boyango, Ilanit; Cohen, Itay; Ali-Saleh, Zenab; Dawood, Marwan; Khamaysi, Ziyad; Yogev, Dean; Avitan-Hersh, Emily
免疫/内分泌
发表日期：2025
文献求助 收藏

miR-184 represses β-catenin and behaves as a skin tumor suppressor

miR-184抑制β-catenin，并发挥皮肤肿瘤抑制因子的作用。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-024-06554-4
Turovsky, Lubov; Kheshaiboun, Ghazal; Yassen, Gharam; Nagosa, Sara; Boyango, Ilanit; Amitai-Lange, Aya; Bhattacharya, Swarnabh; Ilan, Neta; Vlodavsky, Israel; Aberdam, Daniel; Shalom-Feuerstein, Ruby; Avitan-Hersh, Emily
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis.

肝素酶 2 (Hpa2) 的核定位可减弱乳腺癌的生长和转移

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-024-06596-8
Hilwi Maram, Shulman Katherina, Naroditsky Inna, Feld Sari, Gross-Cohen Miriam, Boyango Ilanit, Soboh Soaad, Vornicova Olga, Farhoud Malik, Singh Preeti, Bar-Sela Gil, Goldberg Hadassah, Götte Martin, Sharrocks Andrew D, Li Yaoyong, Sanderson Ralph D, Ilan Neta, Vlodavsky Israel
肿瘤
乳腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

New Heparanase-Inhibiting Triazolo-Thiadiazoles Attenuate Primary Tumor Growth and Metastasis

新型肝素酶抑制剂三唑并噻二唑类化合物可减弱原发肿瘤生长和转移

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers13122959
Barash, Uri; Rangappa, Shobith; Mohan, Chakrabhavi Dhananjaya; Vishwanath, Divakar; Boyango, Ilanit; Basappa, Basappa; Vlodavsky, Israel; Rangappa, Kanchugarakoppal S
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.

肝素酶和化疗协同作用，促进巨噬细胞活化并增强肿瘤生长

期刊:Cancer Research
影响因子:16.6
doi:10.1158/0008-5472.CAN-19-1676
Bhattacharya Udayan, Gutter-Kapon Lilach, Kan Tal, Boyango Ilanit, Barash Uri, Yang Shi-Ming, Liu JingJing, Gross-Cohen Miriam, Sanderson Ralph D, Shaked Yuval, Ilan Neta, Vlodavsky Israel
肿瘤
发表日期：2020
文献求助 收藏

Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer

患者来源的异种移植模型（PDX）可预测基于肝素酶的肺癌疗法的有效性

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.25022
Katz, Amit; Barash, Uri; Boyango, Ilanit; Feld, Sari; Zohar, Yaniv; Hammond, Edward; Ilan, Neta; Kremer, Ran; Vlodavsky, Israel
肺癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Prognostic significance of heparanase expression in primary and metastatic breast carcinoma

肝素酶表达在原发性和转移性乳腺癌中的预后意义

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.23560
Vornicova, Olga; Naroditsky, Inna; Boyango, Ilanit; Shachar, Shlomit S; Mashiach, Tanya; Ilan, Neta; Vlodavsky, Israel; Bar-Sela, Gil
肿瘤
肿瘤免疫
乳腺癌
发表日期：2018
文献求助 收藏

Heparanase: From basic research to therapeutic applications in cancer and inflammation

肝素酶：从基础研究到癌症和炎症的治疗应用

期刊:Drug Resistance Updates
影响因子:21.7
doi:10.1016/j.drup.2016.10.001
Vlodavsky, Israel; Singh, Preeti; Boyango, Ilanit; Gutter-Kapon, Lilach; Elkin, Michael; Sanderson, Ralph D; Ilan, Neta
炎症/感染
肿瘤
炎症
肿瘤免疫
发表日期：2016
文献求助 收藏

The prognostic significance of heparanase expression in metastatic melanoma

肝素酶表达在转移性黑色素瘤中的预后意义

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.12492
Vornicova, Olga; Boyango, Ilanit; Feld, Sari; Naroditsky, Inna; Kazarin, Olga; Zohar, Yaniv; Tiram, Yariv; Ilan, Neta; Ben-Izhak, Ofer; Vlodavsky, Israel; Bar-Sela, Gil
黑色素瘤
发表日期：2016
文献求助 收藏